NEW BRUNSWICK, N.J. — Johnson & Johnson has appointed Ryan Koors as Vice President of Investor Relations, effective May 7, 2026.
Koors will report to Joseph J. Wolk, Executive Vice President and Chief Financial Officer of Johnson & Johnson. He succeeds Darren Snellgrove, who is leaving the company to become chief financial officer of Halozyme.
“Ryan’s appointment underscores the deep bench of financial talent within Johnson & Johnson and our commitment to developing leaders across the Company,” said Mr. Wolk. “With his deep knowledge of our business and proven financial expertise, Ryan is exceptionally well positioned to lead our Investor Relations function and will be a great resource to the investment community as we continue to execute our long-term strategy, drive sustained and accelerating growth and create value for shareholders.”
Koors has more than 20 years of experience in finance leadership roles across Johnson & Johnson’s Innovative Medicine, Research & Development, MedTech and Supply Chain businesses. He most recently served as Chief Financial Officer and Vice President of Finance for Innovative Medicine Global Research & Development, where he provided strategic and financial leadership for the company’s Innovative Medicine Global Research & Development organization.
He previously served as Vice President of Finance for MedTech Surgery and Vice President of Finance for Johnson & Johnson MedTech Supply Chain.
Koors joined Johnson & Johnson in 2002. He holds a bachelor’s degree in finance from Wright State University in Ohio and an MBA from Xavier University.
“I want to thank Darren for his leadership and numerous contributions to Johnson & Johnson,” added Mr. Wolk. “We wish Darren continued success in his new role.”
